Inspire Medical Systems Inc
$ 56.83
3.48%
14 Apr - close price
- Market Cap 1,636,551,000 USD
- Current Price $ 56.83
- High / Low $ 56.95 / 54.34
- Stock P/E 11.62
- Book Value 27.33
- EPS 4.89
- Next Earning Report 2026-05-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.20 %
- 52 Week High 163.35
- 52 Week Low 48.30
About
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.
Analyst Target Price
$76.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-11 | 2025-11-03 | 2025-08-04 | 2025-05-05 | 2025-02-10 | 2024-11-04 | 2024-08-06 | 2024-05-07 | 2024-02-06 | 2023-11-07 | 2023-08-01 | 2023-05-02 |
| Reported EPS | 1.65 | 0.38 | 0.45 | 0.1 | 1.15 | 0.6 | 0.32 | -0.34 | 0.49 | -0.29 | -0.41 | -0.53 |
| Estimated EPS | 0.6789 | -0.19 | 0.2 | -0.23 | 0.72 | 0.06 | -0.14 | -0.65 | -0.09 | -0.58 | -0.57 | -0.66 |
| Surprise | 0.9711 | 0.57 | 0.25 | 0.33 | 0.43 | 0.54 | 0.46 | 0.31 | 0.58 | 0.29 | 0.16 | 0.13 |
| Surprise Percentage | 143.0402% | 300% | 125% | 143.4783% | 59.7222% | 900% | 328.5714% | 47.6923% | 644.4444% | 50% | 28.0702% | 19.697% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-04 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.34 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INSP
2026-04-15 00:10:05
This document is an earnings call transcript for Inspire Medical Systems, Inc. (NYSE:INSP) for its Q2 2025 financial results. It details the company's performance, financial health, and future outlook as discussed during the call.
2026-04-13 04:08:00
Inspire Medical Systems (INSP) is presented as a stronger investment than Alternate Health (AHGIF) due to its superior institutional ownership, profitability, and more favorable analyst ratings. The article highlights Inspire Medical's innovative sleep apnea technology and its strong market position, making it an attractive option in the medical technology sector.
2026-04-11 04:08:40
Inspire Medical Systems (INSP) has experienced a significant 60.8% decline over the past year, prompting an analysis of its current valuation. A Discounted Cash Flow (DCF) model suggests the stock is 57.9% undervalued, predicting an intrinsic value of $134.62 compared to its current price of $56.69. Additionally, its P/E ratio of 11.23x is below both the industry average and Simply Wall St's "Fair Ratio" of 15.66x, further indicating a potential undervaluation.
2026-04-08 19:40:11
Inspire Medical Systems (INSP) is positioned for growth despite its stock dropping significantly this year, driven by product innovation like the Inspire V system and upcoming Inspire VI, increasing patient demand, and strong financial results. However, the company faces challenges with reimbursement uncertainty and short-term procedural disruptions from the WISeR program, leading to cautious 2026 revenue forecasts. Analysts have recently raised their earnings estimates for 2026, suggesting potential upside, and the article also highlights other noteworthy medical stocks like Pacific Biosciences, Phibro Animal Health, and GE HealthCare Technologies.
2026-04-08 04:08:40
Inspire Medical Systems (INSP) is positioned for growth due to product innovation with Inspire V, rising patient demand, and strong financial performance. Despite a significant stock price drop this year and challenges like reimbursement uncertainty and procedural disruptions from the WISeR program, analysts have raised earnings estimates for 2026. This outlook suggests potential for recovery and growth, making it a stock to consider, alongside other top-ranked medical stocks like Pacific Biosciences, Phibro Animal Health, and GE HealthCare Technologies.
2026-04-06 14:41:10
Inspire Medical Systems, Inc. (NYSE: INSP) will release its first quarter 2026 financial results after market close on Monday, May 4. The company's management team will host a conference call at 5:00 p.m. Eastern Time to discuss these results and recent business developments. A replay of the call will be available on Inspire's Investor Relations website for two weeks following the event.
